Incidence and risk factors for chronic kidney disease in individuals with type 1 diabetes: A population‐based study in Salford, Manchester
This large UK cohort study highlights a high burden of CKD among adults with T1D. Key risk factors included older age, higher BMI, poor glycaemic control, smoking and deprivation. Although ACE inhibitors and ARBs were commonly prescribed, the uptake of newer reno-protective treatments was low. These findings point to a need for earlier detection, targeted interventions and broader implementation of effective therapies to reduce kidney disease burden in this population.
Authors
- Hellena Hailu Habte‐Asres (ORCID: https://orcid.org/0000-0001-8141-1423)
- Mike Stedman (ORCID: https://orcid.org/0000-0002-0491-7823)
- Janaka Karalliedde (ORCID: https://orcid.org/0000-0002-2617-8320)
- Angus Forbes (ORCID: https://orcid.org/0000-0003-3331-755X)
- David Collins. Wheeler (ORCID: https://orcid.org/0000-0003-0745-3478)
- Adrian Hugh Heald (ORCID: https://orcid.org/0000-0002-9537-4050)
Institutions
- Royal Free London NHS Foundation Trust (GB)
- King's College London (GB)
- Manchester Academic Health Science Centre (GB)
- The Royal Free Hospital (GB)
- University of Manchester (GB)
- Salford Royal Hospital (GB)
- Roland Hill (United Kingdom) (GB)
- University College London (GB)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1111/dme.70175
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Amgen
- AstraZeneca
- Sanofi
- Astellas Pharma
- Galderma